検索対象:     
報告書番号:
※ 半角英数字
 年 ~ 
 年

The Small-molecule Bcl-2 inhibitor HA14-1 sensitizes cervical cancer cells, but not normal fibroblasts, to heavy-ion radiation

低分子Bcl-2阻害剤HA14-1は子宮頸癌細胞の重粒子線感受性を増強するが正常線維芽細胞は増感しない

浜田 信行*; 片岡 啓子*; 楚良 桜*; 原 孝光*; 大村 素子*; 舟山 知夫; 坂下 哲哉; 中野 隆史*; 小林 泰彦

Hamada, Nobuyuki*; Kataoka, Keiko*; Sora, Sakura*; Hara, Takamitsu*; Omura, Motoko*; Funayama, Tomoo; Sakashita, Tetsuya; Nakano, Takashi*; Kobayashi, Yasuhiko

This is the first study to demonstrate that the small-molecule Bcl-2 inhibitor HA14-1 renders human cervical cancer cells and their Bcl-2 over expressing radioresistant counterparts, but not normal fibroblasts, more susceptible to heavy ions. Thus, Bcl-2 may be an attractive target for improving the efficacy of heavy-ion therapy.

Access

:

- Accesses

InCites™

:

パーセンタイル:70.68

分野:Oncology

Altmetrics

:

[CLARIVATE ANALYTICS], [WEB OF SCIENCE], [HIGHLY CITED PAPER & CUP LOGO] and [HOT PAPER & FIRE LOGO] are trademarks of Clarivate Analytics, and/or its affiliated company or companies, and used herein by permission and/or license.